サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702351

遠隔精神医療の世界市場：2025年～2033年

Global Telepsychiatry Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
遠隔精神医療の世界市場：2025年～2033年
出版日: 2025年04月10日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の遠隔精神医療の市場規模は、2024年に243億6,000万米ドルに達し、2033年には1,026億2,000万米ドルに達すると予測され、2025年～2033年の予測期間中にCAGR 16.6％で成長する見込みです。

遠隔精神医療は、評価、診断、治療、カウンセリングを含む精神科医療の遠隔提供を促進する遠隔医療の専門分野です。ビデオ通話、モバイルアプリケーション、遠隔医療ポータルなどのデジタル通信プラットフォームを活用することで、遠隔精神医療は、メンタルヘルス専門家が直接訪問することなく、患者にタイムリーで効果的なサポートを提供することを可能にします。このアプローチは、特に精神科医療へのアクセスが困難な遠隔地や十分なサービスを受けていない地域の人々にとって、精神保健サービスの効率を高めます。

地理的な障壁を取り除くことで、遠隔精神医療はメンタルヘルス治療へのアクセシビリティを大幅に向上させると同時に、従来の対面診察に代わる便利で費用対効果の高い選択肢を提供します。患者は自宅に居ながらにして治療、投薬管理、危機介入を受けることができ、移動時間や関連費用を削減することができます。遠隔医療技術が進歩し続けるにつれ、遠隔精神医療は世界のヘルスケアシステムの不可欠な一部となりつつあり、メンタルヘルスサービスのギャップを埋め、より多くの人々にケアを拡大するのに役立っています。

メンタルヘルス疾患の有病率の上昇は、世界の遠隔精神医療市場の成長を促進する主な要因の1つです。うつ病、不安障害、双極性障害、統合失調症などの症状は世界中で数100万人に影響を及ぼしており、メンタルヘルス問題は障害の主要な原因となっています。

世界保健機関（WHO）によると、世界では約8人に1人が精神障害を抱えて生活しており、この数はストレス、ライフスタイルの変化、経済的不安、社会的孤立などの要因により増加し続けています。精神科医療に対する需要の高まりは、精神保健の専門家不足と相まって、遠隔精神医療のような革新的でスケーラブルなソリューションに対する緊急の必要性を生み出しています。

遠隔精神医療は、患者と精神科医、セラピスト、カウンセラーを遠隔で結びつけ、地理的な障壁に関係なくタイムリーな介入を可能にすることで、アクセシビリティのギャップを埋めています。これは、メンタルヘルスサービスが乏しい地域や、偏見によって対面診療を受けられないような地域では特に有益です。また、遠隔精神療法の利便性と柔軟性は、より多くの人々が助けを求めることを促し、それによってヘルスケアシステムにおけるメンタルヘルス負担の増大に対処することになります。メンタルヘルスに対する意識が高まり、世界のヘルスケア政策がデジタルヘルスソリューションを優先する中、遠隔精神医療市場は今後数年で大きく拡大する見通しです。

全米精神疾患同盟によると、2021年には米国市民の22.8%が精神疾患を経験しています。さらに、自殺率の増加が市場の成長をさらに加速させています。CDCの報告によると、2021年、自殺は10～14歳および25～34歳の死因の第2位、15～24歳の死因の第3位、35～44歳の死因の第5位を占めています。さらに、急速な技術の進歩とモバイルの普及が遠隔精神医療サービスへのアクセシビリティを高め、市場開拓に拍車をかけています。これらすべての要因が、世界の遠隔精神医療市場に需要をもたらしています。

遠隔精神医学の世界市場の成長を制限している主な課題の1つは、プライバシーとデータセキュリティへの懸念です。遠隔精神医療は、デジタルプラットフォーム、クラウドベースのシステム、電子カルテ（EHR）に依存し、遠隔精神医療相談を促進しています。しかし、このようなテクノロジーへの依存は、データ漏洩、不正アクセス、サイバー脅威に関する重大なリスクを引き起こします。

精神科の病歴、治療セッション、処方箋など、機密性の高い患者情報は、機密保持のために安全に保管・送信されなければなりません。セキュリティに不備があれば、個人情報の盗難やデータの悪用、患者の精神的苦痛につながり、遠隔精神医療サービスに対する信頼が損なわれます。

政府やヘルスケアプロバイダーは、患者の機密性を確保するために、米国のHIPAA（医療保険の相互運用性と説明責任に関する法律）や欧州のGDPR（一般データ保護規則）のような厳格なデータ保護規制を遵守しなければならないです。しかし、世界の規制のばらつき、サイバー攻撃のリスク、第三者のデータ取り扱いに対する懸念は、依然として課題となっています。

多くの患者やヘルスケアプロバイダーは、プライバシーの侵害を恐れて、遠隔精神療法の全面的な導入を躊躇しています。この抑制を克服するために、業界はエンドツーエンドの暗号化、多要素認証、強固なサイバーセキュリティ対策を優先し、患者データを保護し、デジタルメンタルヘルスソリューションに対する信頼を高める必要があります。このように、上記の要因が世界の遠隔精神医療市場の潜在的成長を制限している可能性があります。

当レポートでは、世界の遠隔精神医療市場について調査し、市場の概要とともに、サービスタイプ別、提供形態別、年齢層別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界見通し

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 遠隔精神医療市場、サービスタイプ別

  • 日常的遠隔精神医療
  • 法医学遠隔精神医療
  • 危機遠隔精神医療
  • 在宅遠隔精神医療
  • 共同遠隔精神医療
  • その他

第6章 遠隔精神医学市場、提供形態別

  • ビデオ会議
  • オーディオ遠隔精神医療
  • モバイルおよびアプリベースの遠隔精神医学
  • ウェブベースの遠隔精神医療

第7章 遠隔精神医療市場、年齢層別

  • 小児
  • 成人
  • 高齢者

第8章 遠隔精神医療市場、用途別

  • うつ病と不安障害
  • 心的外傷後ストレス障害（PTSD）
  • 薬物乱用と依存症治療
  • 統合失調症と精神病
  • 双極性障害の治療
  • その他

第9章 遠隔精神医療市場、エンドユーザー別

  • 病院と診療所
  • 病院と診療所
  • 地域精神保健センター
  • 在宅ケア
  • リハビリテーションセンター

第10章 遠隔精神医学市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第11章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第12章 企業プロファイル

  • Access TeleCare, LLC
    • 会社概要
    • 製品ポートフォリオ
    • 主な発展
    • SWOT分析
  • Amedisys.
  • InnovaTel.
  • FasPsych
  • Array Behavioral Care.
  • Brightside Health Inc.
  • Encounter Telehealth
  • Epsychiatry Pty. Ltd.
  • Iris Telehealth Inc.
  • Telemynd
  • MDsafari Inc.
  • Advanced Telemed Services
  • MD Live

第13章 仮定と調査手法

第14章 付録

目次
Product Code: HCIT9436

The global telepsychiatry market reached US$ 24.36 billion in 2024 and is expected to reach US$ 102.62 billion by 2033, growing at a CAGR of 16.6 % during the forecast period of 2025-2033.

Telepsychiatry is a specialized branch of telemedicine that facilitates the remote delivery of psychiatric care, including assessment, diagnosis, treatment, and counseling. By leveraging digital communication platforms such as video calls, mobile applications, and telehealth portals, telepsychiatry enables mental health professionals to provide timely and effective support to patients without requiring in-person visits. This approach enhances the efficiency of mental health services, particularly for individuals in remote or underserved areas who may otherwise struggle to access psychiatric care.

By eliminating geographical barriers, telepsychiatry significantly improves accessibility to mental health treatment while also offering a convenient and cost-effective alternative to traditional in-person consultations. Patients can receive therapy, medication management, and crisis intervention from the comfort of their homes, reducing travel time and associated expenses. As telehealth technology continues to advance, telepsychiatry is becoming an integral part of the global healthcare system, helping to bridge the gap in mental health services and expand care to a wider population.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Mental Health Disorders

The rising prevalence of mental health disorders is one of the primary drivers fueling the growth of the global telepsychiatry market. Conditions such as depression, anxiety, bipolar disorder, and schizophrenia are affecting millions worldwide, with mental health issues becoming a leading cause of disability.

According to the World Health Organization (WHO), approximately one in eight people globally lives with a mental disorder, and this number continues to rise due to factors such as stress, lifestyle changes, economic uncertainties, and social isolation. The growing demand for psychiatric care, combined with a shortage of mental health professionals, has created an urgent need for innovative and scalable solutions like telepsychiatry.

Telepsychiatry is bridging the accessibility gap by connecting patients with psychiatrists, therapists, and counselors remotely, allowing for timely interventions regardless of geographical barriers. This is particularly beneficial in regions where mental health services are scarce or where stigma prevents individuals from seeking in-person care. The convenience and flexibility of telepsychiatry also encourage more people to seek help, thereby addressing the rising mental health burden on healthcare systems. As mental health awareness increases and global healthcare policies prioritize digital health solutions, the telepsychiatry market is poised for significant expansion in the coming years.

According to the National Alliance on Mental Illness, 22.8% of U.S. citizens experienced a mental illness in 2021. Additionally, the increasing suicide rates are further accelerating market growth. The CDC reports that in 2021, suicide was the second-leading cause of death among individuals aged 10-14 and 25-34, the third-leading cause for those aged 15-24, and the fifth-leading cause for individuals between 35 and 44. Furthermore, rapid technological advancements and increasing mobile penetration are enhancing accessibility to telepsychiatry services, fueling further market development. All these factors demand the global telepsychiatry market.

Privacy and Data Security Concerns

One of the major challenges limiting the growth of the global telepsychiatry market is privacy and data security concerns. Telepsychiatry relies on digital platforms, cloud-based systems, and electronic health records (EHRs) to facilitate remote mental health consultations. However, this dependence on technology raises significant risks related to data breaches, unauthorized access, and cyber threats.

Sensitive patient information, including psychiatric histories, therapy sessions, and prescriptions, must be securely stored and transmitted to protect confidentiality. Any security lapse can lead to identity theft, data misuse, or psychological distress for patients, which undermines trust in telepsychiatry services.

Governments and healthcare providers must comply with strict data protection regulations, such as HIPAA (Health Insurance Portability and Accountability Act) in the U.S. and GDPR (General Data Protection Regulation) in Europe, to ensure patient confidentiality. However, variability in global regulations, the risk of cyberattacks, and concerns over third-party data handling continue to pose challenges.

Many patients and healthcare providers remain hesitant to fully embrace telepsychiatry due to fears of compromised privacy. To overcome this restraint, the industry must prioritize end-to-end encryption, multi-factor authentication, and robust cybersecurity measures to safeguard patient data and enhance trust in digital mental health solutions. Thus, the above factors could be limiting the global telepsychiatry market's potential growth.

Segment Analysis

The global telepsychiatry market is segmented based on service type, delivery mode, age group, application, end-user, and region.

Service Type:

The routine telepsychiatry segment in the service type is expected to dominate the global telepsychiatry market with the highest market share

The routine telepsychiatry segment is a crucial aspect of the global telepsychiatry market, focusing on ongoing, regular mental health care provided through digital platforms. This segment involves scheduled consultations between patients and mental health professionals for chronic conditions such as depression, anxiety, bipolar disorder, and post-traumatic stress disorder (PTSD).

Routine telepsychiatry is designed for patients who require long-term management, medication adjustments, and regular therapy sessions to maintain their mental well-being. This segment is particularly valuable because it allows for continuous care without the need for patients to travel to a clinic or psychiatrist's office, offering flexibility and convenience.

Routine telepsychiatry also ensures that mental health professionals can monitor a patient's progress, address any emerging concerns, and make timely treatment adjustments. The rise of chronic mental health conditions, combined with the increasing adoption of telehealth technologies, makes routine telepsychiatry a cost-effective and efficient solution for ongoing psychiatric care.

It is expanding rapidly as both patients and healthcare providers embrace the convenience and accessibility of regular, remote mental health support, helping to address the growing demand for psychiatric services globally. These factors have solidified the segment's position in the global telepsychiatry market.

Geographical Analysis

North America is expected to hold a significant position in the global telepsychiatry market with the highest market share

In North America's telepsychiatry market, the demand for specialized mental health care among older adults is rising, driven by the projected doubling of the 65-and-over population from 48 million to 88 million by 2050. Currently, 14% of older adults live with a mental disorder, falling into two primary patient groups in need of psychiatric care. The first includes individuals with long-standing psychiatric conditions who require specialized geriatric psychiatry services to adapt their treatment to cognitive decline and age-related changes in medication metabolism.

The second group comprises those who develop circumstantial psychiatric challenges later in life due to stressors such as loss, social isolation, and physical health deterioration. Telepsychiatry is emerging as a crucial solution to meet the evolving mental health needs of this growing demographic.

For instance, in January 2024, in New York, Talkiatry, a leading provider of high-quality, in-network psychiatric care, introduced specialized telepsychiatry services for adults aged 65 and older. Committed to enhancing access to expert care for the often-overlooked aging population, Talkiatry leverages its user-friendly telehealth platform and a team of board-certified geriatric psychiatrists to deliver tailored mental health support. Thus, the above factors are consolidating the region's position as a dominant force in the global telepsychiatry market.

Competitive Landscape

The major global players in the telepsychiatry market include Access TeleCare, LLC, Amedisys, InnovaTel., FasPsych, Array Behavioral Care, Brightside Health Inc., Encounter Telehealth, Epsychiatry Pty. Ltd., Iris Telehealth Inc., Telemynd, MDsafari Inc., Advanced Telemed Services, and MD Live among others.

Key Developments

  • In February 2025, the National Tele Mental Health Programme (NTMHP), launched by the government. It is a nationwide initiative aimed at expanding access to mental health care through digital platforms. It serves as the digital extension of the District Mental Health Programme (DMHP), ensuring universal access to mental health services that are equitable, accessible, affordable, and high-quality.
  • In October 2024, the Tele-Mental Health Assistance and Networking Across States (Tele-MANAS) App was launched as a comprehensive digital platform under India's National Tele-Mental Health Programme. Designed for public use, the app features an extensive library of mental health resources, including self-care strategies, guidance on recognizing distress signals, and tools for managing early signs of stress, anxiety, and emotional challenges.
  • In October 2022, the Union Health Ministry introduced Tele-Mental Health Assistance and Networking Across States (Tele-MANAS), a 24/7 tele-mental health service designed to enhance nationwide mental healthcare. This initiative establishes a comprehensive telepsychiatry network, offering services such as counseling, specialist consultations, and e-prescriptions. By integrating digital solutions with mental health support, Tele-MANAS aims to improve accessibility and affordability, reinforcing the growing demand for telepsychiatry services in the region.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global telepsychiatry market report delivers a detailed analysis with 87 key tables, more than 83 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Service Type
  • 2.4. Snippet by Delivery Mode
  • 2.5. Snippet by Age Group
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Mental Health Disorders
      • 3.1.1.2. Growing Awareness and Acceptance of Telepsychiatry
    • 3.1.2. Restraints
      • 3.1.2.1. Privacy and Data Security Concerns
      • 3.1.2.2. Reimbursement Challenges
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Telepsychiatry Market, By Service Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 5.1.2. Market Attractiveness Index By Service Type
  • 5.2. Routine Telepsychiatry*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Forensic Telepsychiatry
  • 5.4. Crisis Telepsychiatry
  • 5.5. In-home Telepsychiatry
  • 5.6. Collaborative Telepsychiatry
  • 5.7. Others

6. Telepsychiatry Market, By Delivery Mode

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 6.1.2. Market Attractiveness Index By Delivery Mode
  • 6.2. Video Conferencing*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Audio Telepsychiatry
  • 6.4. Mobile & App-Based Telepsychiatry
  • 6.5. Web-Based Telepsychiatry

7. Telepsychiatry Market, By Age Group

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 7.1.2. Market Attractiveness Index By Age Group
  • 7.2. Pediatric Telepsychiatry*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Adult Telepsychiatry
  • 7.4. Geriatric Telepsychiatry

8. Telepsychiatry Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Depression and Anxiety Disorders*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Post-Traumatic Stress Disorder (PTSD)
  • 8.4. Substance Abuse and Addiction Treatment
  • 8.5. Schizophrenia and Psychotic Disorders
  • 8.6. Bipolar Disorder Treatment
  • 8.7. Others

9. Telepsychiatry Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals and Clinics
  • 9.4. Community Mental Health Centers
  • 9.5. Homecare Settings
  • 9.6. Rehabilitation Centers

10. Telepsychiatry Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Mexico
      • 10.4.8.2. Brazil
      • 10.4.8.3. Argentina
      • 10.4.8.4. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Access TeleCare, LLC*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
      • 12.1.2.5. Financial Overview
      • 12.1.2.6. Company Revenue
      • 12.1.2.7. Geographical Revenue Shares
      • 12.1.2.8. Revenue Forecasts
    • 12.1.3. Key Developments
      • 12.1.3.1. Mergers & Acquisitions
      • 12.1.3.2. Key Product Development Activities
      • 12.1.3.3. Regulatory Approvals, etc.
    • 12.1.4. SWOT Analysis
  • 12.2. Amedisys.
  • 12.3. InnovaTel.
  • 12.4. FasPsych
  • 12.5. Array Behavioral Care.
  • 12.6. Brightside Health Inc.
  • 12.7. Encounter Telehealth
  • 12.8. Epsychiatry Pty. Ltd.
  • 12.9. Iris Telehealth Inc.
  • 12.10. Telemynd
  • 12.11. MDsafari Inc.
  • 12.12. Advanced Telemed Services
  • 12.13. MD Live

LIST NOT EXHAUSTIVE

13. Assumptions and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us